Arix Bioscience PLC (ARIX)
Holding(s) in Company
20-Oct-2022 / 16:30 GMT/BST
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
GB00BDO45071
Issuer Name
ARIX BIOSCIENCE PLC
UK or Non-UK Issuer
UK
2. Reason for Notification
An acquisition or disposal of voting rights
3. Details of person subject to the notification obligation
Name
Acacia Research Corporation
City of registered office (if applicable)
Country of registered office (if applicable)
4. Details of the shareholder
Name
City of registered office
Country of registered office
Merton Acquisition Holdco LLC
New York
United States
5. Date on which the threshold was crossed or reached
18-Oct-2022
6. Date on which Issuer notified
20-Oct-2022
7. Total positions of person(s) subject to the notification obligation
.
% of voting rights attached to shares (total of 8.A)
% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)
Total of both in % (8.A + 8.B)
Total number of voting rights held in issuer
Resulting situation on the date on which threshold was crossed or reached
25.563559
0.000000
25.563559
33023210
Position of previous notification (if applicable)
22.402098
0.000000
22.402098
28939210
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached
8A. Voting rights attached to shares
Class/Type of shares ISIN code(if possible)
Number of direct voting rights (DTR5.1)
Number of indirect voting rights (DTR5.2.1)
% of direct voting rights (DTR5.1)
% of indirect voting rights (DTR5.2.1)
GB00BD045071
33023210
25.563559
Sub Total 8.A
33023210
25.563559%
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
Type of financial instrument
Expiration date
Exercise/conversion period
Number of voting rights that may be acquired if the instrument is exercised/converted
% of voting rights
Sub Total 8.B1
8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))
Type of financial instrument
Expiration date
Exercise/conversion period
Physical or cash settlement
Number of voting rights
% of voting rights
Sub Total 8.B2
9. Information in relation to the person subject to the notification obligation
2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)
Ultimate controlling person
Name of controlled undertaking
% of voting rights if it equals or is higher than the notifiable threshold
% of voting rights through financial instruments if it equals or is higher than the notifiable threshold
Total of both if it equals or is higher than the notifiable threshold
Acacia Research Corporation
Merton Acquisition Holdco LLC
25.563559
25.563559%
10. In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional Information
Merton Acquisition Holdco LLC is a wholly owned subsidiary of Acacia Research Corporation.
12. Date of Completion
20-Oct-2022
13. Place Of Completion
New York, New York, USA
ISIN: GB00BD045071 Category Code: HOL TIDM: ARIX LEI Code: 213800OVT3AHQCXNIX43 OAM Categories: 2.3. Major shareholding notifications Sequence No.: 195683 EQS News ID: 1468183
End of Announcement EQS News Service